Télécharger le texte intégral - ISPED-Enseignement à distance

184
176. Van Rompay KK, Brignolo LL, Meyer DJ, Jerome C, Tarara R, Spinner A, et al. Biological
effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine
(tenofovir) to newborn and infant rhesus macaques. Antimicrob Agents Chemother
2004;48(5):1469-1487.
177. Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML. Topical
administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against
multiple oral exposures of low doses of simian immunodeficiency virus. J Infect Dis
2002;186(10):1508-1513.
178. Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML.
Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency
virus infection. J Infect Dis 2001;184(4):429-438.
179. Dabis F, Elenga N, Méda N, Leroy V, Viho I, Manigart O, et al. 18-month mortality and
perinatal exposure to zidovudine in West Africa. AIDS 2001;15:771-779.
180. Fowler M, Mwatha A, Guay L, Musoke P, Mmiro F, Flemming T, et al. Effect of Nevirapine
(NVP) for perinatal HIV. Prevention appears greatest among women with most advanced
disease. Sub group analyses of HIVNET 012. In: 9th Conference on Retroviruses and
Opportunistic Infection; February 8-11, 2002; Seattle, USA (abstract 120).
181. Coutsoudis A, Pillay K, Spooner E, Coovadia HM, Pembrey L, Newell ML. Morbidity in
children born to women infected with human immunodeficiency virus in South Africa: does
mode of feeding matter Acta Paediat 2003;92(8):890-895.
182. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding
patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a
prospective cohort study. South African Vitamin A Study Group. Lancet 1999;354(9177):471-
476.
183. Dabis F, Leroy V, Castetbon K, Spira R, Newell ML, Salamon R. Preventing mother-to-child
transmission of HIV-1 in Africa in the year 2000. AIDS 2000;14(8):1017-1026.
184. Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Cost-effective
use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir
Immune Defic Syndr 2000;24(4):369-377.
185. Scotland GS, vanTeijlingen ER, vanderPol M, Smith WCS. A review of studies assessing the
costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-
Saharan Africa. AIDS 2003;17(7):1045-1052.
186. Newell ML, Dabis F, Tolley K, Whynes D. Cost-effectiveness and cost-benefit in the
prevention of mother-to-child transmission of HIV in developing countries. Ghent
International Working Group on Mother-to-Child Transmission of HIV. AIDS
1998;12(13):1571-1780.
187. Mansergh G, Haddix AC, Steketee RW, Simonds RJ. Cost-effectiveness of zidovudine to
prevent mother-to-child transmission of HIV in sub-Saharan Africa. JAMA 1998;280(1):30-
31.
188. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa.
Lancet 2002;359(9320):1851-1856.
189. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in
Africa: a systematic review of the evidence. Lancet 2002;359(9318):1635-1643.